Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study.
Manuel Saenz-de-ViteriSergio Recalde-MaestrePatricia Fernández-RobredoMaría Isabel López GálvezLluís Arias BarquetMarta S FigueroaJosé García-ArumíAlfredo García-Layananull nullPublished in: Acta ophthalmologica (2021)
While SRF is compatible with good visual and anatomical outcomes, IRF leads to worse results in patients with nAMD; our results suggest that patients with IRF have better outcomes when individualized treatment regimens are used (PRN or T&E) in contrast with a FBM regimen.